|
|
|
| Webinar: Unlock Viral Vector Yield and Efficiency with Upstream Intensification | Discover how Repligen's TFDF technology is changing viral vector manufacturing. In this webinar, you’ll learn how high-density, perfusion-based production using HEK293 cells and ready-to-use plasmids can boost AAV and LVV yields by up to 30 times—while keeping quality high. See how this efficient, scalable process helps lower costs and speed up access to life-changing gene therapies and vaccines. Click here to learn more. |
|
|
|
|
By Richard Moroney, Ph.D., Stat Consulting | Even after AI developers clean up hallucinations and other short-term issues, a large-scale workforce replacement faces a few intractable obstacles. | |
|
|
|
| A Holistic Approach To Process Scale-Up | Webinar | Sartorius | Explore an innovative concept that optimizes USP and DSP processes, as well as discover scale-up results and a fully automated and integrative DSP system. |
|
|
|
|
|
| The Importance Of Scalability In Viral Vectors | Article | MilliporeSigma | Diseases that lack a cure, or even treatment, may be addressed with new gene therapeutic classes. This potential has spurred new investments in the drug development and commercialization space. |
|
|
|
|
|
|
|
|
| Webinar: A Case Study for Viral Vector Process Impurity Profile: Evaluation of EndoCleave | Join us for a deep dive into the performance of Roche’s DNA endonuclease, EndoCleave, in AAV and LVV production. This webinar compares EndoCleave to other enzymes across key parameters—concentration, temperature, incubation time, and salt levels—using a HEK293 TTx platform, revealing insights to improve viral vector purity, safety, and scalability in gene therapy manufacturing. Click here to learn more. |
|
|
|
|
|
|
|
|
|
|
|
| Webinar: Scaling Plasmid DNA Production: A Proven Strategy for Higher Yields | With rising demand for plasmid DNA in gene therapies and vaccines, this Thermo Fisher webinar explores how Akron Bio leveraged Gibco™ Bacto™ CD Supreme FPM and peptones to boost productivity. Learn how media and peptone selection, process optimization, and scalable solutions are transforming pDNA development. Gain actionable insights to improve yield and efficiency. Click here to learn more. |
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
Connect With Cell & Gene: |
|
|
|